Non-Invasive Ventilation/Nasal High Flow Therapies (NIV)
Vyaire AirLife™ noninvasive ventilation (NIV) full-face and nasal masks feature a lightweight silicone design that contours to the patient’s face for a comfortable fit. Vented and non-vented options are available in three sizes to suit a wide range of patients.
Features & Benefits
- Flexible swivel connector enables ease in position of the circuit
- Comfortable four-point headgear with crown strap for better stability and sealing
- Adjustable forehead rest for comfort and stability
- Soft seal that conforms to the face, reducing need to overtighten
- Quick release strap
- Made without DEHP
Customer Education Resources
Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.
AirLife™ NIV masks are easy to fit to patients with an adjustable four-point headgear, adjustable forehead rest and quick release clips. Fit the mask to the patient once using the headgear and adjustable forehead rest, then utilize the clips to quickly release the mask and reseal without having to adjust the overall fit.
The AirLife™ NIV masks have a crown strap and soft-seal design to conform to the patient's face, reducing the need to overtighten and enhancing patient comfort. Additionally, the masks feature a flexible double swivel elbow that reduces pull force applied to face mask.
The AirLife™ NIV masks are available in a full face (oro-nasal) or nasal mask format. Additionally, both formats offer elbows with or without venting. All masks are offered in 3 sizes.
The Latest News From Vyaire
“As the leading manufacturer of solutions for the treatment and monitoring of respiratory conditions at every stage of life, Vyaire Medical has been working tirelessly to deliver our ventilator equipment for patients in respiratory distress due to COVID-19, and to the healthcare workers treating
Read MoreCHICAGO – April 3, 2020 – Vyaire Medical, Inc. and CEO Gaurav Agarwal today issued the following update on the company’s response to the coronavirus (COVID-19) pandemic:
Read More